Cameco Corp
NYSE: CCJ · ENERGY · URANIUM
Updated 2026-04-29
Cameco Corp (CCJ) Financial Forecast & Price Target 2030
Research-backed projections from analyst consensus, management guidance, and sector analysis.
Price target summary
Management guidance
No specific CEO revenue targets disclosed in available research data. Latest 2025 annual report filed April 2026 indicates continued focus on long-term uranium supply agreements (India deal $2.6B), but no explicit multi-year revenue guidance through 2030 was found in the sources provided.
Revenue & price projection
Financial forecast — research-backed
| Metric | 2023 | 2024 | 2025 | 2026 (E) | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.6B | $3.1B | $3.5B | $3.5B | $3.9B | $4.3B | $4.7B | $5.2B |
| Revenue growth | — | 21.2% | 10.9% | — | 12.4% | 9.5% | 10.3% | 9.7% |
| EPS | $0.79 | $0.62 | $1.24 | $1.77 | $2.61 | $3.05 | $3.55 | $4.12 |
| P/S ratio | — | — | — | 12.0x | 12.0x | 12.0x | 12.0x | 12.0x |
| Implied price | — | — | — | $101.31 | $112.57 | $112.57 | $135.08 | $146.34 |
Catalysts & risks
Methodology
Cameco Corp's forward estimates are derived from AI-powered research synthesis combining analyst consensus from 7 Wall Street analysts, management guidance from the latest earnings call, and sector growth forecasts from industry research. Revenue and EPS projections use analyst consensus where available and conservative extrapolation with growth deceleration for outer years. Price targets are calculated using a tiered Price-to-Sales (P/S) methodology, where the P/S multiple is determined by the projected revenue growth rate.
WallStSmart proprietary research model · Not financial advice · Past performance is not indicative of future results · Last researched: April 7, 2026.